Gevo appoints K’Lynne Johnson director from Nov. 4
The current Class II term runs to Gevo’s 2027 annual meeting, with an $85,000 annual cash retainer and a $63,000 equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Gevo, Inc. appointed K’Lynne Johnson as a Class II director, effective November 4, 2026. Her current term expires at the annual meeting of stockholders in 2027. Gevo concluded that Johnson is independent under applicable Nasdaq standards.
For her service as a non-employee director, Johnson will receive an annual cash retainer of $85,000 and an equity grant valued at $63,000, subject to the company’s compensation policy. The equity award will be made under Gevo’s Amended and Restated 2010 Stock Incentive Plan. Johnson brings more than three decades of experience and was founder and former President and Chief Executive Officer of Elevance Renewable Sciences.
8-K Event Classification
3 items: 5.02, 7.01, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Annual cash retainer: $85,000
Equity grant: $63,000
Current Class II director term: Through the annual meeting in 2027
+1 more
4 metrics
Annual cash retainer
$85,000
For service as a non-employee director
Equity grant
$63,000
For service as a non-employee director
Current Class II director term
Through the annual meeting in 2027
Term expiration
Leadership experience
More than three decades
K’Lynne Johnson’s innovation and executive leadership experience
Key Terms
Class II director, non-employee director, indemnification agreement, Amended and Restated 2010 Stock Incentive Plan, +1 more
5 terms
Class II director regulatory
"appointed to the Board as a Class II director"
A class II director is a member of a company’s board who belongs to one of several staggered groups of directors, each group standing for election in different years. For investors, this matters because staggered terms slow wholesale board turnover—like rotating members of a neighborhood committee—making sudden changes in control or strategy harder and affecting how quickly shareholders can influence corporate direction.
non-employee director regulatory
"for service as a non-employee director"
indemnification agreement regulatory
"entered into the Company’s customary form of indemnification agreement"
An indemnification agreement is a contract in which one party promises to cover losses, costs, or legal claims that another party might face, acting like a tailored safety net or private insurance policy. For investors, it matters because such agreements shift potential financial risk away from a company or its officers and onto the indemnifier, which can affect a company’s future liabilities, cash flow and how risky the investment appears during deal-making or litigation.
Amended and Restated 2010 Stock Incentive Plan financial
"pursuant to the Company’s Amended and Restated 2010 Stock Incentive Plan"
independent director regulatory
"concluded that Ms. Johnson is an independent director"
An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What compensation will GEVO’s new director receive?
Gevo says K’Lynne Johnson will receive an annual cash retainer of $85,000 and an equity grant valued at $63,000. She is also eligible for annual equity grants and other compensation consistent with the company’s non-employee director compensation policy.
What experience does K’Lynne Johnson bring to GEVO’s board?
Johnson brings more than three decades of innovation and executive leadership experience. She was founder and former President and Chief Executive Officer of Elevance Renewable Sciences, and previously held senior leadership roles at BP Innovene, BP Chemicals, and Amoco.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 23, 2026
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (303 ) 858-8358
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective as of November 4, 2026, the Board of Directors (the “Board”) of Gevo, Inc. (“Gevo” or the “Company”) approved the appointment of K’Lynne Johnson to the Board as a Class II director, with a current term that will expire at the annual meeting of stockholders to be held in 2027. Ms. Johnson will receive an annual cash retainer of $85,000 and an equity grant valued at $63,000 for service as a non-employee director, subject to the Company’s compensation policy for non-employee directors as specified from time to time by the Board. The equity award will be made pursuant to the Company’s Amended and Restated 2010 Stock Incentive Plan. Ms. Johnson will also be eligible to receive annual grants of equity and other compensation consistent with the Company’s compensation policy for her service as a non-employee director, as specified from time to time by the Board. Ms. Johnson also entered into the Company’s customary form of indemnification agreement upon her appointment to the Board.
There are no understandings or arrangements with any person pursuant to which Ms. Johnson was selected as a director, and Ms. Johnson is not party to any related party transaction required to be reported pursuant to Item 404(a) of Regulation S-K.
The Board considered the independence of Ms. Johnson under The Nasdaq Stock Market LLC (“Nasdaq”) listing standards and concluded that Ms. Johnson is an independent director under the applicable Nasdaq standards.
Item 7.01. Regulation FD.
The Company issued the press release attached hereto as Exhibit 99.1 in connection with the appointment of Ms. Johnson to the Board.
The information included in this Current Report under Item 7.01, including Exhibit 99.1, is deemed to be “furnished” and shall not be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act or the Exchange Act.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |||||||
| 99.1 | Press release, dated October 28, 2026 | |||||||
| 104 | Cover Page Interactive Data File (Formatted as Inline XBRL) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GEVO, INC. | ||||||||
| Date: October 28, 2026 | By: | /s/ E. Cabell Massey | ||||||
| E. Cabell Massey | ||||||||
| Vice President, Deputy General Counsel and Corporate Secretary | ||||||||
Exhibit 99.1
 | 345 Inverness Drive South Building C, Suite 310 Englewood, CO 80112 | t 303-858-8358 f 303-858-8431 gevo.com | ||||||
FOR IMMEDIATE RELEASE
Gevo Announces Appointment of K’Lynne Johnson to Board of Directors
ENGLEWOOD, Colo. – October 28, 2026 – Gevo, Inc. (NASDAQ: GEVO) today announced the appointment of K’Lynne Johnson to its Board of Directors. Johnson brings more than three decades of innovation and executive leadership experience spanning sustainable technologies, global research and development, manufacturing operations, and enterprise transformation.
“K’Lynne brings a powerful combination of strategic, operational and governance experience to Gevo,” said Gevo Chief Executive Officer Paul Bloom. “She understands what it takes to commercialize new technologies, scale industrial businesses and navigate significant transformation. Her experience and perspective will be invaluable as we execute Gevo’s next phase of growth and value creation.”
Johnson is an entrepreneurial leader who has successfully delivered results in both building new businesses and transforming existing large traditional commodity organizations. In addition, she has deep experience developing motivated, capable managers, teams and individuals while aligning global, complex organizations to deliver positive results.
Johnson is founder and former President and Chief Executive Officer of Elevance Renewable Sciences, Inc., a specialty chemicals company that developed and commercialized a proprietary technology platform using biobased feedstocks to produce alternatives to conventional petrochemicals and oleochemicals. Before joining Elevance, Johnson held senior leadership roles at BP Innovene Inc., BP Chemicals, and Amoco Corporation.
Johnson currently serves as a director of FMC Corporation, Trinseo PLC, J.M. Huber Corporation, and BlueScope Steel Limited. She also serves as independent board chair of DMC Biotechnologies and previously served on the boards of TPC Group, Sylvatex Corporation, and The Morton Arboretum.
“Gevo has assembled a differentiated portfolio of technologies and operating assets creating meaningful value across low-carbon fuel and carbon markets,” said Johnson. “I am pleased to join the Board and look forward to working with my fellow directors and the management team as Gevo continues to execute its strategy, develop its businesses and pursue long-term growth.”
Johnson holds a Master of Organizational Behavior from the Brigham Young University Marriott School of Management and a Bachelor of Science in Psychology from Brigham Young University.
The addition of K’Lynne Johnson to the Gevo Board of Directors is effective November 4.
About Gevo
Gevo is a next-generation diversified energy company committed to fueling America’s future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural
communities to drive economic growth. Gevo’s innovative technology can be used to make a variety of renewable products, including sustainable aviation fuel (SAF), motor fuels, chemicals, and other materials that provide U.S.-made solutions. Gevo’s business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. Gevo owns and operates an ethanol plant with an adjacent carbon capture and storage (CCS) facility and Class VI carbon-storage well. Gevo also owns and operates one of the largest dairy-based renewable natural gas (RNG) facilities in the United States, turning by-products into clean, reliable energy. Additionally, Gevo developed the world’s first production facility for specialty alcohol-to-jet (ATJ) fuels and chemicals operating since 2012. Gevo is currently developing the world’s first large-scale ATJ facility to be co-located at our North Dakota site. Gevo’s market-driven “pay-for-performance” approach regarding carbon and other sustainability attributes helps deliver value to our local economies. Through its Verity subsidiary, Gevo provides transparency, accountability, and efficiency in tracking, measuring, and verifying various attributes throughout the supply chain. By strengthening rural economies, Gevo is working to secure a self-sufficient future and to make sure value is brought to the market.
For more information, please go to www.gevo.com.
Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, without limitation, including the appointment of K’Lynne Johnson, and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.
Media Contact
Communications@gevo.com
Communications@gevo.com
IR Contact
IR@Gevo.com
IR@Gevo.com